New pill could help babies fight RSV faster
NCT ID NCT07482657
First seen Jun 25, 2026 · Last updated Jul 21, 2026 · Updated 4 times
Summary
This study tests an experimental oral drug called zelicapavir in 150 children aged 1 month to 3 years who have respiratory syncytial virus (RSV). The drug aims to stop the virus from multiplying and speed up recovery. Half the children will get the drug, half a placebo, and researchers will track how quickly symptoms like cough and fever go away.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- zelicapavir (oral suspension)
- What this could lead to
- If successful, this could provide a new oral treatment option for young children with RSV, potentially reducing hospital stays and symptom duration.
- What could go wrong
- This is an early Phase 2 trial with only 150 participants, so results may not confirm effectiveness. The drug may cause side effects or fail to improve recovery compared to placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Center of Excellence for Pediatric Infectious Diseases and Vaccines Faculty of Medicine, Chulalongkorn University (CE-PID)
RECRUITINGBangkok, 10330, Thailand
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Chiangrai Prachanukroh Hospital
RECRUITINGChiang Rai, 57000, Thailand
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Khon Kaen Hospital
RECRUITINGKhon Kaen, 40000, Thailand
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Lampang Hospital
RECRUITINGLampang, 52000, Thailand
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Lamphun Hospital
RECRUITINGLamphun, 51000, Thailand
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Maha Sarakham Hospital
RECRUITINGMaha Sarakham, 44000, Thailand
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Maharaj Nakorn Chiang Mai Hospital
RECRUITINGChiang Mai, 50200, Thailand
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Nakornping Hospital
RECRUITINGChiang Mai, 50180, Thailand
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Nasal spray vaccine aims to shield infants from RSV
- Scientists deliberately infect older adults with RSV to unlock immune secrets
- Could vitamin d levels predict wheezing after bronchiolitis?
- New mRNA vaccine aims to shield against RSV
- Could a simple pill tame RSV? new trial tests obeldesivir
- Massive RSV vaccine study uses real-world data to see if shots prevent severe illness